Performance of a colorectal cancer screening protocol in an economically and medically underserved population

Cancer Prevention Research

Volumn 4, Issue 10, 2011, Pages 1572-1579

  Cai, Shan Rong ^a   Zhang, Su Zhan ^a   Zhu, Hong Hong ^b,c   Huang, Yan Qin ^a   Li, Qi Rong ^d   Ma, Xin Yuan ^d   Yao, Kai Yan ^d   Zheng, Shu ^a  

^a THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b CAPELLA UNIVERSITY   (United States)

^c SAINT LOUIS UNIVERSITY   (United States)

^d Institute of Oncology Prevention and Treatment   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOMATOUS POLYP; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER SCREENING; CHINESE; COLORECTAL ADENOMA; COLORECTAL CANCER; FECAL IMMUNOCHEMICAL TEST; FEMALE; HIG RISK FACTOR QUESTIONNAIRE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE;

ADULT; AGED; CHINA; COHORT STUDIES; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; IMMUNOLOGIC TESTS; MALE; MASS SCREENING; MEDICALLY UNDERSERVED AREA; MIDDLE AGED; OCCULT BLOOD; PATIENT COMPLIANCE; PREDICTIVE VALUE OF TESTS; PREVALENCE; QUESTIONNAIRES; RISK FACTORS; SIGMOIDOSCOPY;

EID: 80053906967     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-10-0377     Document Type: Article

References (26)

1. Chen Z. Recalling a sample survey of the nation's third cause of death. Beijing, P.R.China:PekingUnionMedicalCollegePress;2008. p.16-25.
2. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993;328:1365-71. (Pubitemid 23131388)
3. Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996;348:1472-7. (Pubitemid 26400242)
4. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecaloccult-blood test. Lancet 1996;348:1467-71. (Pubitemid 26400241)
5. Rabeneck L, Paszat LF, Saskin R, Stukel TA. Association between colonoscopy rates and colorectal cancer mortality. Am J Gastroenterol 2010;105:1627-32.
6. Hao Y, Jemal A, Zhang X, Ward EM. Trends in colorectal cancer incidence rates by age, race/ethnicity, and incidences of access to medical care, 1995-2004 (United States). Cancer Causes Control 2009;18:1695-8.
7. Atkin WS, Edwards R, Kralj-Hans I, Wooldrage K, Hart AR, Northover JM, et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet 2010;375:1624-33.
8. Zheng S, Chen K, Liu X, Ma X, Yu H, Yao K, et al. Cluster randomization trial of sequence mass screening for colorectal cancer. Dis Colon Rectum 2003;46:51-8. (Pubitemid 36105831)
9. Chen K, Cai J, Liu XY, Ma XY, Yao KY, Zheng S. Nested case-control study on the risk factors of colorectal cancer. World J Gastroenterol 2003;9:99-103. (Pubitemid 36131287)
10. Zheng S, Liu XY, Ding KF, Wang LB, Qiu PL, Ding XF, et al. Reduction of the incidence and mortality of rectal cancer by polypectomy: a prospective cohort study in Haining County. World J Gastroenterol 2002;8:488-92. (Pubitemid 34692748)
11. Whittemore AS, Wu-Williams AH, Lee M, Zheng S, Gallagher RP, Jiao DA, et al. Diet, physical activity, and colorectal cancer among Chinese in North America and China. J Natl Cancer Inst 1990;82:915-26. (Pubitemid 20176559)
12. Meng W, Cai SR, Zhou L, Dong Q, Zheng S, Zhang SZ. Performance value of high risk factors in colorectal cancer screening in China. World J Gastroenterol 2009;15:6111-6.
13. Ma XY, Wang XH, Lei TH. Epidemiologic trend and occurrence features with colorectal cancer in Jiashan County. Bulletin of Chinese Cancer 2001;10:375-6.
14. Chen K, Qiu Q, Zhang Y. Risk factors of colorectal cancer: a metaanalysis. J Zhejiang Univ (Medical Sci). 2002;31(4):254-8.
15. Hol L, Wilschut JA, van Ballegooijen M, van Vuuren AJ, van der Valk H, Reijerink JC, et al. Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels. Br J Cancer 2009;100:1103-10.
16. Smith RA, Cokkinides V, Brooks D, Saslow D, Brawley OW. Cancer screening in the United States, 2010: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin 2010;60:99-119.
17. Levin B, Lieberman DA, McFarland B, Andrews KS, Brooks D, Bond J, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 2008;134:1570-95. (Pubitemid 351615355)
18. The European Group for Colorectal Cancer Screening. Recommendation to include colorectal cancer screening in public health policy. J Med Screen 1999;6:80-1.
19. Lieberman D. Progress and challenges in colorectal cancer screening and surveillance. Gastroenterology 2010;138:2115-26.
20. Allison JE, Sakoda LC, Levin TR, Tucker JP, Tekawa IS, Cuff T, et al. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics. J Natl Cancer Inst 2007;99:1462-70.
21. Gatto NM, Frucht H, Sundararajan V, Jacobson JS, Grann VR, Neugut AI. Risk of perforation after colonoscopy and sigmoidoscopy: a population-based study. J Natl Cancer Inst 2003;95:230-6. (Pubitemid 36240636)
22. Detsky AS. Screening for colon cancer-can we afford colonoscopy? N Engl J Med 2001;345:607-8. (Pubitemid 32772104)
23. Sarfaty M, Wender R. How to increase colorectal cancer screening rates in practice. CA Cancer J Clin 2007;57:354-66. (Pubitemid 350234401)
24. Selvachandran SN, Hodder RJ, Ballal MS, Jones P, Cade D. Prediction of colorectal cancer by a patient consultation questionnaire and scoring system: a prospective study. Lancet 2002;360:278-83. (Pubitemid 34874719)
25. Jellema P, van der Windt DA, Bruinvels DJ, Mallen CD, van Weyenberg SJ, Mulder CJ, et al. Value of symptoms and additional diagnostic tests for colorectal cancer in primary care: systematic review and meta-analysis. BMJ 2010;340:c1269.
26. Zhu MM, Xu XT, Nie F, Tong JL, Xiao SD, Ran ZH. Comparison of immunochemical and guaiac-based fecal occult blood test in screening and surveillance for advanced colorectal neoplasms: a meta-analysis. J Dig Dis 2010;11:148-60.